Diamyd Medical secures approximately USD 125 million in a funding round with U.S. sector specialist investors to support its Phase 3 trial.
Amount Raised
$125 Million
Round Type
Funding Round
SwedenBiotechnologyHealth CareMedicalTherapeuticsDescription
Diamyd Medical has directed an issue of 17,226,500 new Class B shares, raising approximately SEK 233 million. The total expected gross proceeds, including warrant exercises, could reach approximately SEK 1,166 million. The funding is intended to support the pivotal Phase 3 DIAGNODE-3 trial for treating type 1 diabetes. Randomization for the trial has been completed, involving 321 patients across 57 clinical sites.
Quick answer
Diamyd Medical raised $125 Million in a Funding Round round, dated March 23, 2026. Diamyd Medical is based in Sweden.
- How much did Diamyd Medical raise?
- Diamyd Medical raised $125 Million in a Funding Round round on March 23, 2026.
- What does Diamyd Medical do?
- Diamyd Medical develops precision medicine therapies aimed at preventing and treating Type 1 Diabetes and LADA (Latent Autoimmune Diabetes in Adults).
- Where is Diamyd Medical based and how big is it?
- Diamyd Medical is based in Sweden.
- Who are the decision-makers at Diamyd Medical?
- Fundz holds 1 contact at Diamyd Medical, including the President & CEO. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Medical and Therapeutics around the same time
Companies in the same sectors as Diamyd Medical that raised within 45 days of this round, from Fundz verified event records.
- Citius Oncology raised $37M on May 6, 2026.
- TransCode Therapeutics raised $20M (Funding Round) on April 7, 2026.
- Sonire Therapeutics raised $18M (Series A) on March 31, 2026.
- TippingPoint Biosciences raised $4.5M (Seed) on March 31, 2026.
- Combat Medical raised $3.5M (Series A) on March 12, 2026.
- NexCure raised $19M (Series A) on March 5, 2026.
Who to call at Diamyd Medical, and when
A new round usually means Diamyd Medical is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Diamyd Medical raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Diamyd Medical, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Diamyd Medical. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Diamyd Medical raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Diamyd Medical raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.